A team of researchers and scientists at the York University have recently discovered newer options for treating patients who have been diagnosed with the initial stages of prostate cancer. In view of this the team has discovered plasmas that are of low temperature. For a rather long time now, scientists have been trying to seek and come up with effective ways of treating prostate cancer from the long term perspective.
However, with a lot of improvements and new developments, the medical field has failed to come up with effective ways of dealing with this medical condition. Currently, those who have been diagnosed with tumors are generally treated with focal therapy which includes radiotherapy or for that matter even cryotherapy. But the main problem with this is that despite this also, the disease generally tends to re-occur gradually in the future. This is perhaps because of the underlying radio resistance of certain type of tumor cells which in a way resemble the stem-like cancer cells.
Also, there are several side effects that patients undergoing treatment have to face. As per the reports of the ACS (American Cancer Society) prostate cancer happens to be the 2nd most common form which affects majority of the American men and is it also known to be a major cause of death amongst men. It has also been concluded that one out of seven men would be detected with the disease and the average age has been found out to be 66.
Researchers have also concluded that low temperature plasma may prove to be a cost effective and a more viable option for treating prostate cancer. In this technique scientists make use of tissue samples that is taken from a patient for taking prostate cancer and healthy prostate cells. This in a way forms the basis for understanding the treatment’s effectiveness.